Is spinal muscular atrophy the result of defects in motor neuron processes?

被引:80
作者
Briese, M
Esmaeili, B
Sattelle, DB
机构
[1] Univ Oxford, Dept Human Anat & Genet, MRC Funct Genet Unit, Oxford OX1 3QX, England
[2] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England
基金
英国惠康基金;
关键词
D O I
10.1002/bies.20283
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The hereditary neurodegenerative disease spinal muscular atrophy (SMA) with childhood onset is one of the most common genetic causes of infant mortality. The disease is characterized by selective loss of spinal cord motor neurons leading to muscle atrophy and is the result of mutations in the survival motor neuron (SMIV) gene. The SMN protein has been implicated in diverse nuclear processes including splicing, ribosome formation and gene transcription. Even though the genetic basis of SMA is well understood, it is not clear how defects in these ubiquitous processes result in motor neuron degeneration leaving other tissues unaffected. Recent evidence from animal and cell culture models of SMA points to roles for SMN in neurite outgrowth and axonal transport. Disruption of these functions might be particularly detrimental to motor neurons given their high metabolic demands and precise connectivity requirements, thus providing a possible explanation for the specificity of motor neuron susceptibility in SMA. Understanding the molecular mechanisms of SMN activity in neuronal processes may generate new targets for future therapeutic strategies. BioEssays 27:946-957,2005. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:946 / 957
页数:12
相关论文
共 90 条
[1]
Expression of the survival of motor neuron (SMN) gene in primary neurons and increase in SMN levels by activation of the N-methyl-D-aspartate glutamate receptor [J].
Andreassi, C ;
Patrizi, AL ;
Monani, UR ;
Burghes, AHM ;
Brahe, C ;
Eboli, ML .
NEUROGENETICS, 2002, 4 (01) :29-36
[2]
Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex [J].
Baccon, J ;
Pellizzoni, L ;
Rappsilber, J ;
Mann, M ;
Dreyfuss, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :31957-31962
[3]
Bassell GJ, 1998, J NEUROSCI, V18, P251
[4]
Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system [J].
Battaglia, G ;
Princivalle, A ;
Forti, F ;
Lizier, C ;
Zeviani, M .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1961-1971
[5]
Subcellular distribution of survival motor neuron (SMN) protein:: possible involvement in nucleocytoplasmic and dendritic transport [J].
Béchade, C ;
Rostaing, P ;
Cisterni, C ;
Kalisch, R ;
La Bella, V ;
Pettmann, B ;
Triller, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (01) :293-304
[6]
GENETIC HOMOGENEITY BETWEEN CHILDHOOD-ONSET AND ADULT-ONSET AUTOSOMAL RECESSIVE SPINAL MUSCULAR-ATROPHY [J].
BRAHE, C ;
SERVIDEI, S ;
ZAPPATA, S ;
RICCI, E ;
TONALI, P ;
NERI, G .
LANCET, 1995, 346 (8977) :741-742
[7]
Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein [J].
Brahms, H ;
Meheus, L ;
De Brabandere, V ;
Fischer, U ;
Lührmann, R .
RNA, 2001, 7 (11) :1531-1542
[8]
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy [J].
Brichta, L ;
Hofmann, Y ;
Hahnen, E ;
Siebzehnrubl, FA ;
Raschke, H ;
Blumcke, I ;
Eyupoglu, IY ;
Wirth, B .
HUMAN MOLECULAR GENETICS, 2003, 12 (19) :2481-2489
[9]
Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly:: implications for spinal muscular atrophy [J].
Buhler, D ;
Raker, V ;
Lührmann, R ;
Fischer, U .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2351-2357
[10]
When is a deletion not a deletion? When it is converted [J].
Burghes, AHM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :9-15